Neurorehabilitation in Parkinson's Disease: A Critical Review of Cognitive Rehabilitation Effects on Cognition and Brain

María Díez-Cirarda, Naroa Ibarretxe-Bilbao, Javier Peña, Natalia Ojeda, María Díez-Cirarda, Naroa Ibarretxe-Bilbao, Javier Peña, Natalia Ojeda

Abstract

Background: Parkinson's disease (PD) patients experience cognitive impairment which has been related to reduced quality of life and functional disability. These symptoms usually progress until dementia occurs. Some studies have been published assessing the efficacy of cognitive treatments on improving cognition, functional outcome, and producing changes in brain activity.

Objective: A critical review was performed to present up-to-date neurorehabilitation effects of cognitive rehabilitation in PD, with special emphasis on the efficacy on cognition, quality of life aspects, brain changes, and the longitudinal maintenance of these changes.

Results: After exclusions, 13 studies were reviewed, including 6 randomized controlled trials for the efficacy on cognition, 2 randomized controlled trials regarding the brain changes after cognitive training, and 5 studies which evaluated the long-term effects of cognitive treatments.

Conclusions: Cognitive rehabilitation programs have demonstrated to be effective on improving cognitive functions, but more research is needed focusing on the efficacy on improving behavioral aspects and producing brain changes in patients with PD. Moreover, there is a need of randomized controlled trials with long-term follow-up periods.

Figures

Figure 1
Figure 1
Summary of studies identified and included in the review.

References

    1. Hirsch L., Jette N., Frolkis A., Steeves T., Pringsheim T. The incidence of Parkinson’s disease: a systematic review and meta-analysis. 2016;46(4):292–300. doi: 10.1159/000445751.
    1. Xia R., Mao Z.-H. Progression of motor symptoms in Parkinson’s disease. 2012;28(1):39–48. doi: 10.1007/s12264-012-1050-z.
    1. Tolosa E., Gaig C., Santamaria J., Compta Y. Diagnosis and the premotor phase of Parkinson disease. 2009;72(7) Supplement 2:S12–S20. doi: 10.1212/WNL.0b013e318198db11.
    1. Muslimovic D., Post B., Speelman J. D., Schmand B. Cognitive profile of patients with newly diagnosed Parkinson disease. 2005;65(8):1239–1245. doi: 10.1212/01.wnl.0000180516.69442.95.
    1. Yarnall A. J., Breen D. P., Duncan G. W., et al. Characterizing mild cognitive impairment in incident Parkinson disease: the ICICLE-PD study. 2014;82(4):308–316. doi: 10.1212/WNL.0000000000000066.
    1. Hely M. A., Reid W. G. J., Adena M. A., Halliday G. M., Morris J. G. L. The Sydney multicenter study of Parkinson’s disease: the inevitability of dementia at 20 years. 2008;23(6):837–844. doi: 10.1002/mds.21956.
    1. Hoogland J., Boel J. A., de Bie R. M. A., et al. Mild cognitive impairment as a risk factor for Parkinson’s disease dementia. 2017;32(7):1056–1065. doi: 10.1002/mds.27002.
    1. Leroi I., McDonald K., Pantula H., Harbishettar V. Cognitive impairment in Parkinson disease: impact on quality of life, disability, and caregiver burden. 2012;25(4):208–214. doi: 10.1177/0891988712464823.
    1. Rosenthal E., Brennan L., Xie S., et al. Association between cognition and function in patients with Parkinson disease with and without dementia. 2010;25(9):1170–1176. doi: 10.1002/mds.23073.
    1. Melzer T. R., Watts R., MacAskill M. R., et al. Grey matter atrophy in cognitively impaired Parkinson’s disease. 2012;83(2):188–194. doi: 10.1136/jnnp-2011-300828.
    1. Duncan G. W., Firbank M. J., Yarnall A. J., et al. Gray and white matter imaging: a biomarker for cognitive impairment in early Parkinson’s disease? 2016;31(1):103–110. doi: 10.1002/mds.26312.
    1. Zheng Z., Shemmassian S., Wijekoon C., Kim W., Bookheimer S. Y., Pouratian N. DTI correlates of distinct cognitive impairments in Parkinson’s disease. 2014;35(4):1325–1333. doi: 10.1002/hbm.22256.
    1. Matsui H., Nishinaka K., Oda M., Niikawa H., Kubori T., Udaka F. Dementia in Parkinson’s disease: diffusion tensor imaging. 2007;116(3):177–181. doi: 10.1111/j.1600-0404.2007.00838.x.
    1. Rektor I., Svátková A., Vojtíšek L., et al. White matter alterations in Parkinson’s disease with normal cognition precede grey matter atrophy. 2018;13(1, article e0187939) doi: 10.1371/journal.pone.0187939.
    1. Cabeza R., Nyberg L. Imaging cognition II: an empirical review of 275 PET and fMRI studies. 2000;12(1):1–47. doi: 10.1162/08989290051137585.
    1. Christopher L., Strafella A. P. Neuroimaging of brain changes associated with cognitive impairment in Parkinson’s disease. 2013;7(2):225–240. doi: 10.1111/jnp.12015.
    1. Williams-Gray C. H., Mason S. L., Evans J. R., et al. The CamPaIGN study of Parkinson’s disease: 10-year outlook in an incident population-based cohort. 2013;84(11):1258–1264. doi: 10.1136/jnnp-2013-305277.
    1. Johnson D. K., Langford Z., Garnier-Villarreal M., Morris J. C., Galvin J. E. Onset of mild cognitive impairment in Parkinson disease. 2016;30(2):127–133. doi: 10.1097/WAD.0000000000000088.
    1. Ramírez–Ruiz B., Martí M. J., Tolosa E., et al. Longitudinal evaluation of cerebral morphological changes in Parkinson’s disease with and without dementia. 2005;252(11):1345–1352. doi: 10.1007/s00415-005-0864-2.
    1. Zhang Y., Wu I. W., Tosun D., Foster E., Schuff N., the Parkinson’s Progression Markers Initiative Progression of regional microstructural degeneration in Parkinson’s disease: a multicenter diffusion tensor imaging study. 2016;11(10, article e0165540) doi: 10.1371/journal.pone.0165540.
    1. Huang C., Tang C., Feigin A., et al. Changes in network activity with the progression of Parkinson’s disease. 2007;130(7):1834–1846. doi: 10.1093/brain/awm086.
    1. Segura B., Ibarretxe-Bilbao N., Sala-Llonch R., et al. Progressive changes in a recognition memory network in Parkinson’s disease. 2013;84(4):370–378. doi: 10.1136/jnnp-2012-302822.
    1. Mak E., Su L., Williams G. B., O'Brien J. T. Neuroimaging correlates of cognitive impairment and dementia in Parkinson’s disease. 2015;21(8):862–870. doi: 10.1016/j.parkreldis.2015.05.013.
    1. Bahar-Fuchs A., Clare L., Woods B. Cognitive training and cognitive rehabilitation for persons with mild to moderate dementia of the Alzheimer’s or vascular type: a review. 2013;5(4):p. 35. doi: 10.1186/alzrt189.
    1. Wykes T., Spaulding W. D. Thinking about the future cognitive remediation therapy—what works and could we do better? 2011;37(Supplement 2):S80–S90. doi: 10.1093/schbul/sbr064.
    1. Hindle J. V., Petrelli A., Clare L., Kalbe E. Nonpharmacological enhancement of cognitive function in Parkinson’s disease: a systematic review. 2013;28(8):1034–1049. doi: 10.1002/mds.25377.
    1. Biundo R., Weis L., Fiorenzato E., Antonini A. Cognitive rehabilitation in Parkinson’s disease: is it feasible? 2017;32(7):840–860. doi: 10.1093/arclin/acx092.
    1. Walton C. C., Naismith S. L., Lampit A., Mowszowski L., Lewis S. J. G. Cognitive training in Parkinson’s disease: a theoretical perspective. 2017;31(3):207–216. doi: 10.1177/1545968316680489.
    1. Lawrence B. J., Gasson N., Bucks R. S., Troeung L., Loftus A. M. Cognitive training and noninvasive brain stimulation for cognition in Parkinson’s disease: a meta-analysis. 2017;31(7):597–608. doi: 10.1177/1545968317712468.
    1. Leung I. H. Cognitive training in Parkinson disease. 2015;85:1–9.
    1. Peña J., Ibarretxe-Bilbao N., García-Gorostiaga I., Gomez-Beldarrain M. A., Díez-Cirarda M., Ojeda N. Improving functional disability and cognition in Parkinson disease: randomized controlled trial. 2014;83(23):2167–2174. doi: 10.1212/WNL.0000000000001043.
    1. Petrelli A., Kaesberg S., Barbe M. T., et al. Effects of cognitive training in Parkinson’s disease: a randomized controlled trial. 2014;20(11):1196–1202. doi: 10.1016/j.parkreldis.2014.08.023.
    1. Cerasa A., Gioia M. C., Salsone M., et al. Neurofunctional correlates of attention rehabilitation in Parkinson’s disease: an explorative study. 2014;35(8):1173–1180. doi: 10.1007/s10072-014-1666-z.
    1. Edwards J. D., Hauser R. A., O'Connor M. L., Valdés E. G., Zesiewicz T. A., Uc E. Y. Randomized trial of cognitive speed of processing training in Parkinson disease. 2013;81(15):1284–1290. doi: 10.1212/WNL.0b013e3182a823ba.
    1. París A. P., Saleta H. G., de la Cruz Crespo Maraver M., et al. Blind randomized controlled study of the efficacy of cognitive training in Parkinson’s disease. 2011;26(7):1251–1258. doi: 10.1002/mds.23688.
    1. Cella M., Preti A., Edwards C., Dow T., Wykes T. Cognitive remediation for negative symptoms of schizophrenia: a network meta-analysis. 2017;52:43–51. doi: 10.1016/j.cpr.2016.11.009.
    1. Zimmermann R., Gschwandtner U., Benz N., et al. Cognitive training in Parkinson disease: cognition-specific vs nonspecific computer training. 2014;82(14):1219–1226. doi: 10.1212/WNL.0000000000000287.
    1. Díez-Cirarda M., Ojeda N., Peña J., et al. Increased brain connectivity and activation after cognitive rehabilitation in Parkinson’s disease: a randomized controlled trial. 2017;11(6):1640–1651. doi: 10.1007/s11682-016-9639-x.
    1. Sinforiani E., Banchieri L., Zucchella C., Pacchetti C., Sandrini G. Cognitive rehabilitation in Parkinson’s disease. 2004;38:387–391. doi: 10.1016/j.archger.2004.04.049.
    1. Reuter I., Mehnert S., Sammer G., Oechsner M., Engelhardt M. Efficacy of a multimodal cognitive rehabilitation including psychomotor and endurance training in Parkinson’s disease. 2012;2012:15. doi: 10.1155/2012/235765.235765
    1. Díez-Cirarda M., Ojeda N., Peña J., et al. Long-term effects of cognitive rehabilitation on brain, functional outcome and cognition in Parkinson’s disease. 2018;25(1):5–12. doi: 10.1111/ene.13472.
    1. Petrelli A., Kaesberg S., Barbe M. T., et al. Cognitive training in Parkinson’s disease reduces cognitive decline in the long term. 2015;22(4):640–647. doi: 10.1111/ene.12621.
    1. Hindle J. V., Watermeyer T. J., Roberts J., et al. Cognitive rehabilitation for Parkinson’s disease dementia: a study protocol for a pilot randomised controlled trial. 2016;17(1):p. 152. doi: 10.1186/s13063-016-1253-0.
    1. A’Campo L. E. I., Spliethoff-Kamminga N. G. A., Macht M., Roos R. A. C., The EduPark Consortium Caregiver education in Parkinson’s disease: formative evaluation of a standardized program in seven European countries. 2010;19(1):55–64. doi: 10.1007/s11136-009-9559-y.
    1. Adamski N., Adler M., Opwis K., Penner I. K. A pilot study on the benefit of cognitive rehabilitation in Parkinson’s disease. 2016;9(3):153–164. doi: 10.1177/1756285616628765.

Source: PubMed

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

3
Abonneren